Enanta Pharmaceuticals
ENTA
#8238
Rank
A$0.49 B
Marketcap
A$16.98
Share price
3.39%
Change (1 day)
-7.93%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of June 2026 : A$0.43 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are A$0.43 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-09-30A$0.42 B-22.03%
2024-09-30A$0.54 B-24.27%
2023-09-30A$0.71 B23.22%
2022-09-30A$0.58 B-3.81%
2021-09-30A$0.60 B-10.55%
2020-09-30A$0.67 B-6.48%
2019-09-30A$0.72 B26.5%
2018-09-30A$0.57 B37.73%
2017-09-30A$0.41 B13.05%
2016-09-30A$0.36 B4.94%
2015-09-30A$0.35 B97.3%
2014-09-30A$0.17 B41.73%
2013-09-30A$0.12 B149.15%
2012-09-30A$50.37 M88.04%
2011-09-30A$26.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$288.95 B 66,402.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$171.45 B 39,361.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$197.75 B 45,413.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$40.13 B 9,137.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$189.97 B 43,623.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$129.92 B 29,802.65%๐Ÿ‡บ๐Ÿ‡ธ USA